Welcome to MS Australia
News
Alemtuzumab (Lemtrada®), one of the approved treatments for relapsing MS in Australia, is being reviewed as a first line therapy by regulatory bodies overseas. The European Medicines Agency (EMA) has started a safety review of alemtuzumab based on new reports overseas of rare but potentially serious side effects affecting the heart, blood vessels, liver and immune system.
The Australian sponsor of alemtuzumab has notified the...
Blog
Over my seven years of working as a support worker, I had the privilege of sharing my time with several amazing individuals who lived with Progressive MS.Reflecting upon this period in my life, I am flooded with emotions and memories of the fantastic people that I spent time with on a weekly basis.People will often quote time as the most valuable thing you can give someone, but it was perhaps something I found hard to quantify or wrap my head around, until spending time with people one-on-one...
Events
Tweets by @MS_Australia
Tweets by MS_AustraliaSupport & Services
As the national peak body for Australians living with MS, we work closely with the state MS societies to help you connect with the right support and services.